+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Formulation of novel sustained release rifampicin-loaded solid lipid microparticles based on structured lipid matrices from Moringa oleifera



Formulation of novel sustained release rifampicin-loaded solid lipid microparticles based on structured lipid matrices from Moringa oleifera



Pharmaceutical Development and Technology 20(5): 546-554



To formulate sustained release rifampicin-loaded solid lipid microparticles (SLMs) using structured lipid matrices based on Moringa oil (MO) and Phospholipon 90G (P90G). Rifampicin-loaded and unloaded SLMs were formulated by melt homogenization and characterized in terms of particle morphology and size, percentage drug content (PDC), pH stability, stability in simulated gastric fluid (SGF, pH 1.2), minimum inhibitory concentration (MIC) and in vitro release. In vivo release was studied in Wistar rats. Rifampicin-loaded SLMs had particle size range of 32.50 ± 2.10 to 34.0 ± 8.40 μm, highest PDC of 87.6% and showed stable pH. SLMs had good sustained release properties with about 77.1% release at 12 h in phosphate buffer (pH 6.8) and 80.3% drug release at 12 h in simulated intestinal fluid (SIF, pH 7.4). SLMs exhibited 48.51% degradation of rifampicin in SGF at 3 h, while rifampicin pure sample had 95.5% degradation. Formulations exhibited MIC range of 0.781 to 1.562, 31.25 to 62.5 and 6.25 to 12.5 μg/ml against Salmonella typhi, Escherichia coli, and Bacillus subtilis respectively and had higher in vivo absorption than the reference rifampicin (p < 0.05). Rifampicin-loaded SLMs could be used once daily for the treatment tuberculosis.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 053288531

Download citation: RISBibTeXText

PMID: 24964095

DOI: 10.3109/10837450.2014.898654


Related references

Formulation development and evaluation of the anti-malaria properties of sustained release artesunate-loaded solid lipid microparticles based on phytolipids. Drug Delivery 22(5): 652-665, 2016

Sustained release paclitaxel-loaded core-shell-structured solid lipid microparticles for intraperitoneal chemotherapy of ovarian cancer. Artificial Cells, Nanomedicine, and Biotechnology 47(1): 957-967, 2019

Formulation and characterization of hydrochlorothiazide solid lipid microparticles based on lipid matrices of Irvingia fat. International Journal of Pharmaceutical Investigation 4(4): 189-194, 2014

Formulation and Evaluation of Novel Solid Lipid Microparticles for the Sustained Release of Ofloxacin. Pharmaceutical Nanotechnology 5(4): 329-341, 2017

Formulation and evaluation of novel solid lipid microparticles as a sustained release system for the delivery of metformin hydrochloride. Drug Delivery 20(3-4): 102-111, 2014

Formulation and evaluation of verapamil hydrochloride loaded solid lipid microparticles. Die Pharmazie 66(1): 24-30, 2011

In vivo evaluation of solid lipid microparticles and hybrid polymer-lipid microparticles for sustained delivery of leuprolide. European Journal of Pharmaceutics and Biopharmaceutics 142: 315-321, 2019

Formulation, in vitro and in vivo evaluation of halofantrine-loaded solid lipid microparticles. Pharmaceutical Development and Technology 2014: 1-8, 2014

Formulation, optimization, and characterization of rifampicin-loaded solid lipid nanoparticles for the treatment of tuberculosis. Drug Development and Industrial Pharmacy 44(12): 1975-1989, 2018

Effect of binary solid lipid matrix of wax and triglyceride on lipid crystallinity, drug-lipid interaction and drug release of ibuprofen-loaded solid lipid nanoparticles (SLN) for dermal delivery. Journal of Colloid and Interface Science 504: 247-256, 2017

Ivabradine Loaded Solid Lipid Microparticles: Formulation, Characterization and Optimization by Central Composite Rotatable Design. Acta Poloniae Pharmaceutica 74(1): 211-226, 2018

Preparation and in vitro evaluation of salbutamol-loaded lipid microparticles for sustained release pulmonary therapy. Journal of Microencapsulation 29(3): 225-233, 2012

Sustained-release diclofenac potassium-loaded solid lipid microparticle based on solidified reverse micellar solution: in vitro and in vivo evaluation. Journal of Microencapsulation 30(4): 335-345, 2013

New solid lipid microparticles for controlled ibuprofen release: formulation and characterization study. International Journal of Pharmaceutics 422(1-2): 59-67, 2012

Solid lipid microparticles: formulation, preparation, characterisation, drug release and applications. Expert Opinion on Drug Delivery 2(1): 75-87, 2005